A Multicenter, Open-label Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of 150µg of Nestorone and 15µg of Ethinyl Estradiol (150/15 NES/EE CVR)
Phase of Trial: Phase III
Latest Information Update: 04 Nov 2015
At a glance
- Drugs Elcometrine (Primary) ; Ethinylestradiol (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- 22 Jun 2008 The expected completion date for this trial is now 1 Jun 2009 according to ClinicalTrials.gov.
- 22 Jun 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.
- 11 Apr 2007 New trial record.